Geneva: The World Health Organization (WHO) will soon begin testing three existing drugs used for other diseases to identify if they are able to help patients sickened by the deadly coronavirus disease. Issuing a statement on Wednesday, the U.N. health agency said that the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19.Also Read - Uttar Pradesh Reports First Zika Virus Case in Kanpur, Team of Experts Sent From Delhi

The drugs were chosen by an independent panel based on the likelihood they could prevent deaths in people hospitalised for coronavirus. They include artesunate, a malaria drug, the cancer drug imatinib, and infliximab, currently used in people with diseases of the immune system. Also Read - Bihar: Gaya Residents to Face Legal Action If Unvaccinated; Will not Be Entitled to Receive Food on Subsidised Rate

WHO’s ongoing study into COVID-19 treatments previously assessed four drugs. Among its findings, the agency determined that remdesivir and hydroxychloroquine didn’t help people hospitalised with the virus. WHO’s research includes thousands of researchers in hundreds of hospitals in 52 countries. Also Read - Over 17,000 Covid-19 Vaccine Doses Given to Inmates in Delhi Jails; Tihar Records the Highest

Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need, says WHO director-general Tedros Adhanom Ghebreyesus.

(With Agency Inputs)